These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11758628)

  • 21. Warfarin monitoring in ambulatory older individuals receiving antimicrobial therapy.
    Raebel MA; Witt DM; Carroll NM; Magid DJ
    Pharmacotherapy; 2005 Aug; 25(8):1055-61. PubMed ID: 16207095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulant treatment of patients with chronic atrial fibrillation in primary health care in Sweden--a retrospective study of incidence and quality in a registered population.
    Nilsson GH; Björholt I; Krakau I
    Fam Pract; 2004 Dec; 21(6):612-6. PubMed ID: 15465879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Managing warfarin treatment in a small Icelandic rural practice in Húsavík].
    Kristinsson VH
    Laeknabladid; 2005 Sep; 91(9):657-60. PubMed ID: 16155336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-management of anticoagulation.
    Levi M
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):979-85. PubMed ID: 18666848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulation in atrial fibrillation. Is there a gap in care for ambulatory patients?
    Putnam W; Nicol K; Anderson D; Brownell B; Chiasson M; Burge FI; Flowerdew G; Cox J
    Can Fam Physician; 2004 Sep; 50():1244-50. PubMed ID: 15508374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum.
    Garcia DA; Witt DM; Hylek E; Wittkowsky AK; Nutescu EA; Jacobson A; Moll S; Merli GJ; Crowther M; Earl L; Becker RC; Oertel L; Jaffer A; Ansell JE;
    Ann Pharmacother; 2008 Jul; 42(7):979-88. PubMed ID: 18559954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Warfarin prevalence, indications for use and haemorrhagic events.
    Ouirke W; Cahill M; Perera K; Sargent J; Conway J
    Ir Med J; 2007 Mar; 100(3):402-4. PubMed ID: 17491542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Self testing and self management of oral anticoagulants with warfarin].
    Nadav L; Schwartz J
    Harefuah; 2003 Sep; 142(8-9):621-3, 645, 644. PubMed ID: 14518167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
    Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
    Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective anticoagulation therapy: defining the gap between clinical studies and clinical practice.
    Wittkowsky AK
    Am J Manag Care; 2004 Oct; 10(10 Suppl):S297-306; discussion S312-7. PubMed ID: 15605700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: a retrospective study on electronic patient records.
    Nilsson GH; Björholt I
    BMC Clin Pharmacol; 2004 Feb; 4():1. PubMed ID: 15028124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Search for predictors of nontherapeutic INR results with warfarin therapy.
    McGriff-Lee NJ; Csako G; Chen JT; Dang DK; Rosenfeld KG; Cannon RO; Macklin LR; Wesley RA;
    Ann Pharmacother; 2005 Dec; 39(12):1996-2002. PubMed ID: 16288081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.
    Phillips KW; Ansell J
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):57-70. PubMed ID: 18095907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety of warfarin therapy in the nursing home setting.
    Gurwitz JH; Field TS; Radford MJ; Harrold LR; Becker R; Reed G; DeBellis K; Moldoff J; Verzier N
    Am J Med; 2007 Jun; 120(6):539-44. PubMed ID: 17524757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What to do when warfarin therapy goes too far.
    Prasad S; Wootten MR; Kulinski N; Chapman SA
    J Fam Pract; 2009 Jul; 58(7):346-52. PubMed ID: 19607771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility, cost-effectiveness and patients' acceptance of point-of-care INR testing in a hospital-based anticoagulation clinic.
    Kong MC; Lim TG; Ng HJ; Chan YH; Lee LH
    Ann Hematol; 2008 Nov; 87(11):905-10. PubMed ID: 18604535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prescribing guidance pocket chart on the initiation of warfarin therapy in a geriatric hospital: a useful but challenging tool].
    Siguret V; N'Guyen A; Harboun M; Chevallier A; Pautas E; Gouin-Thibault I; Berigaud S
    Ann Biol Clin (Paris); 2006; 64(3):245-51. PubMed ID: 16698560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of the switch from a branded to a generic warfarin sodium product: an observer-blinded, randomized, crossover study.
    Lee HL; Kan CD; Yang YJ
    Clin Ther; 2005 Mar; 27(3):309-19. PubMed ID: 15878384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monitoring age-dependent effect of anticoagulation treatment in patients with atrial fibrillation].
    Hnátek T; Zogala D; Kameník L; Kotík I; Jerábek I; Zavoral M
    Vnitr Lek; 2008 Jan; 54(1):21-4. PubMed ID: 18390113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.